表紙
市場調查報告書
商品編碼
1076496

全球體外受精市場:按設備、程序類型、最終用途、地區、按細分市場預測(2022-2030 年)的市場規模/份額/趨勢分析

In Vitro Fertilization Market Size, Share & Trends Analysis Report By Instrument (Disposable Devices, Culture Media, Capital Equipment), By Procedure Type, By End Use, By Region, And Segment Forecasts, 2022 - 2030

出版日期: | 出版商: Grand View Research, Inc. | 英文 120 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

預計 2022 年至 2030 年間,全球體外受精 (IVF) 市場將以 5.9% 的複合年增長率增長,到 2030 年將達到 374 億美元。

市場受到市場參與者的持續努力、政府制定更好的醫療費用政策以及生活方式改變導致不孕症發病率增加的推動。此外,擴大用於生育治療的胞漿內精子注射劑有望在不久的將來對市場增長產生積極影響。

本報告對全球體外受精 (IVF) 市場進行研究和分析,並提供市場趨勢、細分/區域市場分析和競爭條件。

目錄

第一章調查方法及範圍

第2章執行摘要

第 3 章市場變量、趨勢、範圍

  • 市場體系展望
  • 市場細分
  • 滲透率和增長前景映射
  • 臨床試驗
  • 用戶視角分析
  • 市場動態
  • 商業環境分析工具

第 4 章體外受精 (IVF) 市場:按程序類型分析

  • 體外受精 (IVF):按程序類型分列的市場份額分析 (2021/2030)
  • 細分儀表板
  • 全球體外受精 (IVF) 程序市場:按程序類型 (2017-2030)
  • 市場規模、預測、趨勢分析:按程序類型(2017-2030)

第 5 章體外受精 (IVF) 市場:按最終用途分析

  • 體外受精 (IVF):按最終用途分列的市場份額分析 (2021/2030)
  • 細分儀表板
  • 市場規模、預測、趨勢分析:按最終用途(2017-2030 年)

第 6 章體外受精 (IVF) 市場:設備分析

  • 體外受精 (IVF):市場份額分析 (2021/2030)
  • 細分儀表板
  • 全球體外受精 (IVF) 市場:按設備 (2021-2030)
  • 市場規模、預測、趨勢分析:按設備分類(2017-2030)

第七章區域展望

  • 各地區市場份額分析(2021 年和 2030 年)
  • 區域市場概況
  • SWOT 分析:按因素(政治/法律、經濟/技術)
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東/非洲
  • 生育診所列表
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東/非洲
  • 市場規模、預測、趨勢分析(2021 年至 2030 年)
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東/非洲

第8章競爭分析

  • 戰略框架/競爭分類(主要創新者、市場領導者、初創企業)
  • 供應商情況
    • 戰略映射
    • 推出新產品
    • 合併/收購
    • 產品認證
    • 合作夥伴
    • 營銷推廣
  • 企業市場分析
  • 公司簡介
    • OvaScience, Inc.
    • Vitrolife AB (publ)
    • Emd Serono, Inc.
    • FUJIFILM Irvine Scientific
    • The Cooper Companies, Inc.
    • Thermo Fisher Scientific, Inc.
    • Bayer AG
    • Merck & Co., Inc.
    • Cook Medical LLC (Cook Group)
    • Genea Biomedx
    • Progyny, Inc.
    • Boston IVF
    • Ferring Pharmaceutical B.V.

第9章 建議事項

目錄
Product Code: 978-1-68038-823-7

In Vitro Fertilization Market Growth & Trends:

The global in vitro fertilization market size is expected to reach USD 37.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.9% from 2022 to 2030. The market is driven by the continuous efforts of the market players, government initiatives to make available better reimbursement policies, and an increase in the incidence of infertility due to lifestyle changes. Expansion of fertility procedures such as ICSI for treating infertility is expected to positively impact the market growth in the near future.

Moreover, the availability of genomic testing facilities that enable the prevention of the transfer of genetic disorders during In Vitro Fertilization (IVF) is further expected to drive the IVF market. The insurance providers are providing coverage for IVF procedures owing to an increase in the number of IVF treatments. This has led to competitive pricing and has moderated the IVF treatment costs as the procedure has been a successfully practiced technology, driving the market with more treatment automation and standardization.

A decline in the Total Fertility Rate (TFR) is a result of factors such as a behavioral shift in society. These factors include a shift from rural to urban societies, the increased age of the first birth, postponement of marriage, an increasing number of women employees, and lower marriage rates. In March 2020, the in-person fertility treatments in U.S. and Canada were suspended due to the COVID-19by the American Society of Reproductive Medicine and Canadian Fertility and Andrology Society. However, treatment is resuming in many countries with the ease of COVID-19 restrictions. The research findings published by the Obstetrics and Gynecology journal, in January 2022 reported COVID-19 vaccines won't harm IVF outcomes. This is expected to prove significant in promoting the uptake of IVF in eligible vaccinated individuals.

In Vitro Fertilization Market Report Highlights:

  • The culture media segment dominated the market in terms of revenue in 2021. A number of research activities are being undertaken to improve the efficiency of cultural media. For instance, Vitrolife showcased its research on SpermFreeze solution at the American Society for Reproductive Medicine (ASRM) that established the effectiveness of its solution for sperm recovery and sperm-hyaluronic acid-binding
  • Europe dominated the market for procedures and instruments in 2021. Adoption of advanced technologies such as time-lapse microscopy by the clinics, availability of affordable treatment, and adherence to medical standards contribute to its market dominance
  • In APAC, the market is expected to witness increased demand for IVF owing to fertility tourism and the availability of funding for the treatment. In Japan, eligible couples can apply for co-funding for a maximum of three cycles with USD 1,920 for each cycle
  • The developing countries in the Asia Pacific region are undertaking legal reforms to promote treatment adoption in the region. For instance, in February 2020, the Government of India approved a bill for the regulation of clinics offering reproduction assistance services, including IVF, artificial insemination, and surrogacy
  • In January 2020, Merck received Marketing Authorization (MA) from the European Commission (EC) for its recombinant human follicle-stimulating hormone, GONAL-f (follitropin alfa) 150 IU pen

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Procedure type
    • 1.1.2 End-use
    • 1.1.3 Instrument
    • 1.1.4 Regional Scope
    • 1.1.5 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
    • 1.6.2 Volume Price Analysis
  • 1.7 List of Secondary Sources
  • 1.8 List of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2
    • 1.9.3 Objective 3

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
    • 2.2.1 Procedure Type
    • 2.2.2 End-use
    • 2.2.3 Instrument
    • 2.2.4 Region
  • 2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
  • 3.2 Market Segmentation
  • 3.3 Penetration & Growth Prospect Mapping
  • 3.4 Clinical Trials
  • 3.5 User Perspective Analysis
    • 3.5.1 Consumer Behavior Analysis
    • 3.5.2 Market Influencer Analysis
  • 3.6 Market Dynamics
    • 3.6.1 Market Driver Analysis
      • 3.6.1.1 Rising reprotourism
      • 3.6.1.2 Technological advancements in IVF
      • 3.6.1.3 Favorable government funding
      • 3.6.1.4 Late initiation of family
      • 3.6.1.5 Increasing incidence rate of male and female infertility
      • 3.6.1.6 Mergers and acquisitions (M&A)
    • 3.6.2 Market Restraint Analysis
      • 3.6.2.1 High cost of IVF treatment
      • 3.6.2.2 Lack of regulatory framework and uniform regulations
      • 3.6.2.3 Vulnerability of women depending on cross-border reprotourism market
  • 3.7 Business Environment Analysis Tools
    • 3.7.1 Porter's five forces analysis
      • 3.7.1.1 Bargaining power of buyers: Low
      • 3.7.1.2 Bargaining power of suppliers: Moderate
      • 3.7.1.3 Competitive rivalry: High
      • 3.7.1.4 Threat of new entrants: Moderate
      • 3.7.1.5 Threat of substitutes: Low
    • 3.7.2 SWOT Analysis, by PESTEL
      • 3.7.2.1 Political & legal
      • 3.7.2.2 Economic
      • 3.7.2.3 Technological
    • 3.7.3 Major Deals & Strategic Alliances Analysis
      • 3.7.3.1 Joint ventures
      • 3.7.3.2 Mergers & acquisitions
    • 3.7.4 Qualitative Analysis: Impact of COVID-19 on IVF Market
    • 3.7.5 Impact of COVID-19 Pandemic: Country Analysis
      • 3.7.5.1 U.S.
      • 3.7.5.2 Canada
      • 3.7.5.3 U.K.
      • 3.7.5.4 Germany
      • 3.7.5.5 France
      • 3.7.5.6 Spain
      • 3.7.5.7 Italy
      • 3.7.5.8 Netherlands, Switzerland, and Belgium
      • 3.7.5.9 Japan
      • 3.7.5.10 India
      • 3.7.5.11 China
      • 3.7.5.12 Brazil
      • 3.7.5.13 Mexico
      • 3.7.5.14 South Africa

Chapter 4 In Vitro Fertilization Market: Procedure Type Analysis

  • 4.1 In Vitro Fertilization by Procedure Type Market Share Analysis, 2021 & 2030
  • 4.2 Segment Dashboard
  • 4.3 Global In Vitro Fertilization Procedures Market, by Type, 2017 - 2030
  • 4.4 Market Size and Forecasts and Trend Analysis, 2017 - 2030 for the Type
    • 4.4.1 Fresh Nondonor
      • 4.4.1.1 Fresh non-donor market, 2017 - 2030 (USD Million)
    • 4.4.2 Frozen Nondonor
      • 4.4.2.1 Frozen non-donor market, 2017 - 2030 (USD Million)
    • 4.4.3 Fresh Donor
      • 4.4.3.1 Fresh donor market, 2017 - 2030 (USD Million)
    • 4.4.4 Frozen Donor
      • 4.4.4.1 Frozen donor market, 2017 - 2030 (USD Million)

Chapter 5 In Vitro Fertilization Market: End-use Analysis

  • 5.1 In Vitro Fertilization End-use Market Share Analysis, 2021 and 2030
  • 5.2 Segment Dashboard
  • 5.3 Market Size and Forecasts and Trend Analysis, 2017 - 2030 for the Following End-Use
    • 5.3.1 Fertility Clinics
      • 5.3.1.1 Fertility clinics market, 2017 - 2030 (USD Million)
    • 5.3.2 Hospitals and Other Settings
      • 5.3.2.1 Hospitals and other settings market, 2017 - 2030 (USD Million)

Chapter 6 In Vitro Fertilization Market: Instrument Analysis

  • 6.1 In Vitro Fertilization (IVF) Market Share Analysis, 2021 & 2030
  • 6.2 Segment Dashboard
  • 6.3 Global IVF Market, by Instrument, 2021 to 2030
  • 6.4 Market Size & Forecasts and Trend Analysis, 2017 to 2030 for the Instrument:
    • 6.4.1 Culture Media
      • 6.4.1.1 Culture media market, 2017 - 2030 (USD Million)
    • 6.4.2 Disposable Devices
      • 6.4.2.1 Disposable devices market, 2017 - 2030 (USD Million)
    • 6.4.3 Capital Equipment
      • 6.4.3.1 Capital equipment market, 2017 - 2030 (USD Million)

Chapter 7 Regional Outlook

  • 7.1 Regional market share analysis, 2021 & 2030
  • 7.2 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
  • 7.3 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
    • 7.3.1 North America
    • 7.3.2 Europe
    • 7.3.3 Asia Pacific
    • 7.3.4 Latin America
    • 7.3.5 MEA
  • 7.4 List of Few Fertility Clinics
    • 7.4.1 North America
    • 7.4.2 Europe
    • 7.4.3 Asia Pacific
    • 7.4.4 Latin America
    • 7.4.5 MEA
  • 7.5 Market Size, & Forecasts and Trend Analysis, 2021 to 2030
    • 7.5.1 North America
      • 7.5.1.1 North America Ivf market, 2017 - 2030 (USD Million)
      • 7.5.1.2 U.S.
      • 7.5.1.2.1 U.S. IVF market, 2017 - 2030 (USD Million)
      • 7.5.1.3 Canada
      • 7.5.1.3.1 Canada IVF market, 2017 - 2030 (USD Million)
    • 7.5.2 Europe
      • 7.5.2.1 Europe IVF market, 2017 - 2030 (USD Million)
      • 7.5.2.2 France
      • 7.5.2.2.1 France IVF market, 2017 - 2030 (USD Million)
      • 7.5.2.3 Germany
      • 7.5.2.3.1 Germany IVF market, 2017 - 2030 (USD Million)
      • 7.5.2.4 Italy
      • 7.5.2.4.1 Italy IVF market, 2017 - 2030 (USD Million)
      • 7.5.2.5 Spain
      • 7.5.2.5.1 Spain IVF market, 2017 - 2030 (USD Million)
      • 7.5.2.6 U.K.
      • 7.5.2.6.1 U.K. IVF market, 2017 - 2030 (USD Million)
      • 7.5.2.7 Belgium
      • 7.5.2.7.1 Belgium IVF market, 2017 - 2030 (USD Million)
      • 7.5.2.8 Netherlands
      • 7.5.2.8.1 Netherlands IVF market, 2017 - 2030 (USD Million)
      • 7.5.2.9 Switzerland
      • 7.5.2.9.1 Switzerland IVF market, 2017 - 2030 (USD Million)
    • 7.5.3 Asia Pacific
      • 7.5.3.1 Asia Pacific IVF market, 2017 - 2030 (USD Million)
      • 7.5.3.2 Japan
      • 7.5.3.2.1 Japan IVF market, 2017 - 2030 (USD Million)
      • 7.5.3.3 China
      • 7.5.3.3.1 China IVF market, 2017 - 2030 (USD Million)
      • 7.5.3.4 India
      • 7.5.3.4.1 India IVF market, 2017 - 2030 (USD Million)
    • 7.5.4 Latin America
      • 7.5.4.1 Latin America IVF market, 2017 - 2030 (USD Million)
      • 7.5.4.2 Brazil
      • 7.5.4.2.1 Brazil IVF market, 2017 - 2030 (USD Million)
      • 7.5.4.3 Mexico
      • 7.5.4.3.1 Mexico IVF market, 2017 - 2030 (USD Million)
    • 7.5.5 Middle East & Africa
      • 7.5.5.1 MEA IVF market, 2017 - 2030 (USD Million)
      • 7.5.5.2 South Africa
      • 7.5.5.2.1 South Africa IVF market, 2017 - 2030 (USD Million)

Chapter 8 Competitive Analysis

  • 8.1 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
  • 8.2 Vendor Landscape
    • 8.2.1 Strategy Mapping
    • 8.2.2 Launch of New Products
    • 8.2.3 Merger and Acquisition
    • 8.2.4 Product Approvals
    • 8.2.5 Partnerships
    • 8.2.6 Marketing & Promotions
  • 8.3 Company Market Position Analysis
  • 8.4 Company Profiles
    • 8.4.1 OvaScience, Inc.
      • 8.4.1.1Company overview
      • 8.4.1.2 Financial performance
      • 8.4.1.3 Product benchmarking
      • 8.4.1.4 Strategic initiatives
      • 8.4.1.5 SWOT analysis
    • 8.4.2 Vitrolife AB (publ)
      • 8.4.2.1Company overview
      • 8.4.2.2 Financial performance
      • 8.4.2.3 Product benchmarking
      • 8.4.2.4 Strategic initiatives
      • 8.4.2.5 SWOT analysis
    • 8.4.3 Emd Serono, Inc.
      • 8.4.3.1 Company overview
      • 8.4.3.2 Financial performance
      • 8.4.3.3 Product benchmarking
      • 8.4.3.4 Strategic initiatives
      • 8.4.3.5 SWOT analysis
    • 8.4.4 FUJIFILM Irvine Scientific
      • 8.4.4.1 Company overview
      • 8.4.4.2 Financial performance
      • 8.4.4.3 Product benchmarking
      • 8.4.4.4 Strategic initiatives
      • 8.4.4.5 SWOT analysis
    • 8.4.5 The Cooper Companies, Inc.
      • 8.4.5.1 Company overview
      • 8.4.5.2 Financial performance
      • 8.4.5.3 Product benchmarking
      • 8.4.5.4 Strategic initiatives
      • 8.4.5.5 SWOT analysis
    • 8.4.6 Thermo Fisher Scientific, Inc.
      • 8.4.6.1 Company overview
      • 8.4.6.2 Financial performance
      • 8.4.6.3 Product benchmarking
      • 8.4.6.4 Strategic initiatives
      • 8.4.6.5 SWOT analysis
    • 8.4.7 Bayer AG
      • 8.4.7.1Company overview
      • 8.4.7.2 Financial performance
      • 8.4.7.3 Product benchmarking
      • 8.4.7.4 Strategic initiatives
      • 8.4.7.5 SWOT analysis
    • 8.4.8 Merck & Co., Inc.
      • 8.4.8.1Company overview
      • 8.4.8.2 Financial performance
      • 8.4.8.3 Product benchmarking
      • 8.4.8.4 Strategic initiatives
      • 8.4.8.5 SWOT analysis
    • 8.4.9 Cook Medical LLC (Cook Group)
      • 8.4.9.1 Company overview
      • 8.4.9.2 Financial performance
      • 8.4.9.3 Product benchmarking
      • 8.4.9.4 Strategic initiatives
    • 8.4.10 Genea Biomedx
      • 8.4.10.1 Company overview
      • 8.4.10.2 Financial Performance
      • 8.4.10.3 Product benchmarking
      • 8.4.10.4 Strategic initiatives
    • 8.4.11 Progyny, Inc.
      • 8.4.11.1Company overview
      • 8.4.11.2 Financial performance
      • 8.4.11.3 Services benchmarking
      • 8.4.11.4 Strategic initiatives
    • 8.4.12 Boston IVF
      • 8.4.12.1Company overview
      • 8.4.12.2Financial performance
      • 8.4.12.3 Product benchmarking
      • 8.4.12.4 Strategic initiatives
    • 8.4.13 Ferring Pharmaceutical B.V.
      • 8.4.13.1Company overview
      • 8.4.13.2 Financial performance
      • 8.4.13.3 Product benchmarking
      • 8.4.13.4 Strategic initiatives

Chapter 9 Recommendations

  • 9.1 Key Insights

List of Tables

  • 1. List of secondary sources
  • 2. List of abbreviations
  • 3. Clinical trial analysis
  • 4. Comparison between the fresh and frozen donor treatment (U.S.)
  • 5. Canadian law on ART
  • 6. Status of public funding for IVF in Canada
  • 7. Global disposable devices market estimates and forecast, 2017 - 2030 (USD Billion)
  • 8. Global culture media market estimates and forecast, 2017 - 2030 (USD Billion)
  • 9. Global capital equipment market estimates and forecast, 2017 - 2030 (USD Billion)
  • 10. Global fresh donor market estimates and forecast, 2017 - 2030 (USD Billion)
  • 11. Global frozen donor market estimates and forecast, 2017 - 2030 (USD Billion)
  • 12. Global fresh non-donor equipment market estimates and forecast, 2017 - 2030 (USD Billion)
  • 13. Global frozen non-donor market estimates and forecast, 2017 - 2030 (USD Billion)
  • 14. Global fertility clinics market estimates and forecast, 2017 - 2030 (USD Billion)
  • 15. Global hospitals & others setting market estimates and forecast, 2017 - 2030 (USD Billion)
  • 16. North America in vitro fertilization market estimates and forecast, 2017 - 2030 (USD Billion)
  • 17. North America in vitro fertilization market revenue estimates and forecast by instrument, 2017 - 2030 (USD Billion)
  • 18. North America in vitro fertilization market revenue estimates and forecast by procedure type, 2017 - 2030 (USD Billion)
  • 19. North America in vitro fertilization market revenue estimates and forecast by end use, 2017 - 2030 (USD Billion)
  • 20. U.S. in vitro fertilization market estimates and forecast, 2017 - 2030 (USD Billion)
  • 21. U.S. in vitro fertilization market revenue estimates and forecast by instrument, 2017 - 2030 (USD Billion)
  • 22. Canada in vitro fertilization market revenue estimates and forecast by procedure type, 2017 - 2030 (USD Billion)
  • 23. Canada in vitro fertilization market revenue estimates and forecast by end use, 2017 - 2030 (USD Billion)
  • 24. Europe in vitro fertilization market estimates and forecast, 2017 - 2030 (USD Billion)
  • 25. Europe in vitro fertilization market revenue estimates and forecast by instrument, 2017 - 2030 (USD Billion)
  • 26. Europe in vitro fertilization market revenue estimates and forecast by procedure type, 2017 - 2030 (USD Billion)
  • 27. Europe in vitro fertilization market revenue estimates and forecast by end use, 2017 - 2030 (USD Billion)
  • 28. France in vitro fertilization market estimates and forecast, 2017 - 2030 (USD Billion)
  • 29. France in vitro fertilization market revenue estimates and forecast by instrument, 2017 - 2030 (USD Billion)
  • 30. France in vitro fertilization market revenue estimates and forecast by procedure type, 2017 - 2030 (USD Billion)
  • 31. France in vitro fertilization market revenue estimates and forecast by end use, 2017 - 2030 (USD Billion)
  • 32. Germany in vitro fertilization market estimates and forecast, 2017 - 2030 (USD Billion)
  • 33. Germany in vitro fertilization market revenue estimates and forecast by instrument, 2017 - 2030 (USD Billion)
  • 34. Germany in vitro fertilization market revenue estimates and forecast by procedure type, 2017 - 2030 (USD Billion)
  • 35. Germany in vitro fertilization market revenue estimates and forecast by end use, 2017 - 2030 (USD Billion)
  • 36. Italy in vitro fertilization market estimates and forecast, 2017 - 2030 (USD Billion)
  • 37. Italy in vitro fertilization market revenue estimates and forecast by instrument, 2017 - 2030 (USD Billion)
  • 38. Italy in vitro fertilization market revenue estimates and forecast by procedure type, 2017 - 2030 (USD Billion)
  • 39. Italy in vitro fertilization market revenue estimates and forecast by end use, 2017 - 2030 (USD Billion)
  • 40. Spain in vitro fertilization market estimates and forecast, 2017 - 2030 (USD Billion)
  • 41. Spain in vitro fertilization market revenue estimates and forecast by instrument, 2017 - 2030 (USD Billion)
  • 42. Spain in vitro fertilization market revenue estimates and forecast by procedure type, 2017 - 2030 (USD Billion)
  • 43. Spain in vitro fertilization market revenue estimates and forecast by end use, 2017 - 2030 (USD Billion)
  • 44. U.K. in vitro fertilization market estimates and forecast, 2017 - 2030 (USD Billion)
  • 45. U.K. in vitro fertilization market revenue estimates and forecast by instrument, 2017 - 2030 (USD Billion)
  • 46. U.K. in vitro fertilization market revenue estimates and forecast by procedure type, 2017 - 2030 (USD Billion)
  • 47. U.K. in vitro fertilization market revenue estimates and forecast by end use, 2017 - 2030 (USD Billion)
  • 48. Belgium in vitro fertilization market estimates and forecast, 2017 - 2030 (USD Billion)
  • 49. Belgium in vitro fertilization market revenue estimates and forecast by instrument, 2017 - 2030 (USD Billion)
  • 50. Belgium in vitro fertilization market revenue estimates and forecast by procedure type, 2017 - 2030 (USD Billion)
  • 51. Belgium in vitro fertilization market revenue estimates and forecast by end use, 2017 - 2030 (USD Billion)
  • 52. Netherlands in vitro fertilization market estimates and forecast, 2017 - 2030 (USD Billion)
  • 53. Netherlands in vitro fertilization market revenue estimates and forecast by instrument, 2017 - 2030 (USD Billion)
  • 54. Netherlands in vitro fertilization market revenue estimates and forecast by procedure type, 2017 - 2030 (USD Billion)
  • 55. Netherlands in vitro fertilization market revenue estimates and forecast by end use, 2017 - 2030 (USD Billion)
  • 56. Switzerland in vitro fertilization market estimates and forecast, 2017 - 2030 (USD Billion)
  • 57. Switzerland in vitro fertilization market revenue estimates and forecast by instrument, 2017 - 2030 (USD Billion)
  • 58. Switzerland in vitro fertilization market revenue estimates and forecast by procedure type, 2017 - 2030 (USD Billion)
  • 59. Switzerland in vitro fertilization market revenue estimates and forecast by end use, 2017 - 2030 (USD Billion)
  • 60. Asia Pacific in vitro fertilization market estimates and forecast, 2017 - 2030 (USD Billion)
  • 61. Asia Pacific in vitro fertilization market revenue estimates and forecast by instrument, 2017 - 2030 (USD Billion)
  • 62. Asia Pacific in vitro fertilization market revenue estimates and forecast by procedure type, 2017 - 2030 (USD Billion)
  • 63. Asia Pacific in vitro fertilization market revenue estimates and forecast by end use, 2017 - 2030 (USD Billion)
  • 64. Japan in vitro fertilization market estimates and forecast, 2017 - 2030 (USD Billion)
  • 65. Japan in vitro fertilization market revenue estimates and forecast by instrument, 2017 - 2030 (USD Billion)
  • 66. Japan in vitro fertilization market revenue estimates and forecast by procedure type, 2017 - 2030 (USD Billion)
  • 67. Japan in vitro fertilization market revenue estimates and forecast by end use, 2017 - 2030 (USD Billion)
  • 68. China in vitro fertilization market estimates and forecast, 2017 - 2030 (USD Billion)
  • 69. China in vitro fertilization market revenue estimates and forecast by instrument, 2017 - 2030 (USD Billion)
  • 70. China in vitro fertilization market revenue estimates and forecast by procedure type, 2017 - 2030 (USD Billion)
  • 71. China in vitro fertilization market revenue estimates and forecast by end use, 2017 - 2030 (USD Billion)
  • 72. India in vitro fertilization market estimates and forecast, 2017 - 2030 (USD Billion)
  • 73. India in vitro fertilization market revenue estimates and forecast by instrument, 2017 - 2030 (USD Billion)
  • 74. India in vitro fertilization market revenue estimates and forecast by procedure type, 2017 - 2030 (USD Billion)
  • 75. India in vitro fertilization market revenue estimates and forecast by end use, 2017 - 2030 (USD Billion)
  • 76. Latin America in vitro fertilization market estimates and forecast, 2017 - 2030 (USD Billion)
  • 77. Latin America in vitro fertilization market revenue estimates and forecast by instrument, 2017 - 2030 (USD Billion)
  • 78. Latin America in vitro fertilization market revenue estimates and forecast by procedure type, 2017 - 2030 (USD Billion)
  • 79. Latin America in vitro fertilization market revenue estimates and forecast by end use, 2017 - 2030 (USD Billion)
  • 80. Brazil in vitro fertilization market estimates and forecast, 2017 - 2030 (USD Billion)
  • 81. Brazil in vitro fertilization market revenue estimates and forecast by instrument, 2017 - 2030 (USD Billion)
  • 82. Brazil in vitro fertilization market revenue estimates and forecast by procedure type, 2017 - 2030 (USD Billion)
  • 83. Brazil in vitro fertilization market revenue estimates and forecast by end use, 2017 - 2030 (USD Billion)
  • 84. Mexico in vitro fertilization market estimates and forecast, 2017 - 2030 (USD Billion)
  • 85. Mexico in vitro fertilization market revenue estimates and forecast by instrument, 2017 - 2030 (USD Billion)
  • 86. Mexico in vitro fertilization market revenue estimates and forecast by procedure type, 2017 - 2030 (USD Billion)
  • 87. Mexico in vitro fertilization market revenue estimates and forecast by end use, 2017 - 2030 (USD Billion)
  • 88. Middle East & Africa in vitro fertilization market estimates and forecast, 2017 - 2030 (USD Billion)
  • 89. Middle East & Africa in vitro fertilization market revenue estimates and forecast by instrument, 2017 - 2030 (USD Billion)
  • 90. Middle East & Africa in vitro fertilization market revenue estimates and forecast by procedure type, 2017 - 2030 (USD Billion)
  • 91. Middle East & Africa in vitro fertilization market revenue estimates and forecast by end use, 2017 - 2030 (USD Billion)
  • 92. South Africa in vitro fertilization market estimates and forecast, 2017 - 2030 (USD Billion)
  • 93. South Africa in vitro fertilization market revenue estimates and forecast by instrument, 2017 - 2030 (USD Billion)
  • 94. South Africa in vitro fertilization market revenue estimates and forecast by procedure type, 2017 - 2030 (USD Billion)
  • 95. South Africa in vitro fertilization market revenue estimates and forecast by end use, 2017 - 2030 (USD Billion)

List of Figures

  • 1. Market research process
  • 2. Data triangulation techniques
  • 3. Primary research pattern
  • 4. Market research approaches
  • 5. Supply-chain-based sizing & forecasting
  • 6. QFD modeling for market share assessment
  • 7. Market formulation & validation
  • 8. In Vitro Fertilization (IVF) market summary, 2021 (USD Million)
  • 9. In Vitro Fertilization (IVF) market segmentation
  • 10. Penetration & growth prospect mapping
  • 11. Market trends & outlook
  • 12. Market driver relevance analysis (Current & future impact)
  • 13. Semen sample imported in Brazil (Units)
  • 14. Female age-based chance of conception
  • 15. Market restraint relevance analysis (Current & future impact)
  • 16. IVF market: Type movement analysis
  • 17. IVF market type outlook: Key takeaways
  • 18. Global IVF procedures market, by procedure type, 2017 - 2030 (USD Million)
  • 19. Fresh non-donor market, 2017 - 2030 (USD Million)
  • 20. Frozen non-donor market 2017 - 2030 (USD Million)
  • 21. Fresh donor market 2017 - 2030 (USD Million)
  • 22. Frozen donor market 2017 - 2030 (USD Million)
  • 23. IVF market: End-use movement analysis
  • 24. IVF market end-use outlook: Key takeaways
  • 25. Fertility clinics market, 2017 - 2030 (USD Million)
  • 26. Hospitals and other settings market, 2017 - 2030 (USD Million)
  • 27. In Vitro Fertilization (IVF) market: Instrument movement analysis
  • 28. IVF market Instrument outlook: Key takeaways
  • 29. IVF instrument market, 2017 - 2030 (USD Million)
  • 30. Culture media market, 2017 - 2030 (USD Million)
  • 31. Disposable devices market, 2017 - 2030 (USD Million)
  • 32. Capital equipment market, 2017 - 2030 (USD Million)
  • 33. Regional outlook, 2021 & 2030
  • 34. Regional marketplace: Key takeaways
  • 35. North America IVF market, 2017 - 2030 (USD Million)
  • 36. U.S. IVF market, 2017 - 2030 (USD Million)
  • 37. Canada IVF market, 2017 - 2030 (USD Million)
  • 38. Europe IVF market, 2017 - 2030 (USD Million)
  • 39. France IVF market, 2017 - 2030 (USD Million)
  • 40. Germany IVF market, 2017 - 2030 (USD Million)
  • 41. Italy IVF market, 2017 - 2030 (USD Million)
  • 42. Spain IVF market, 2017 - 2030 (USD Million)
  • 43. U.K. IVF market, 2017 - 2030 (USD Million)
  • 44. Belgium IVF market, 2017 - 2030 (USD Million)
  • 45. Netherlands IVF market, 2017 - 2030 (USD Million)
  • 46. Switzerland IVF market, 2017 - 2030 (USD Million)
  • 47. Asia Pacific IVF market, 2017 - 2030 (USD Million)
  • 48. Japan IVF market, 2017 - 2030 (USD Million)
  • 49. China IVF market, 2017 - 2030 (USD Million)
  • 50. India IVF market, 2017 - 2030 (USD Million)
  • 51. Latin America IVF market, 2017 - 2030 (USD million)
  • 52. Brazil IVF market, 2017 - 2030 (USD million)
  • 53. Mexico IVF market, 2017 - 2030 (USD million)
  • 54. MEA IVF market, 2017 - 2030 (USD Million)
  • 55. South Africa IVF market, 2017 - 2030 (USD million)
  • 56. Strategy framework
  • 57. Strategy mapping
  • 58. Company market position analysis